Recovery Housing and Drug Abuse Treatment Outcome
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Aims To conduct a randomized, controlled trial of abstinence-contingent recovery housing delivered with or without intensive day treatment among individuals exiting residential opioid detoxification.
Design Random assignment to one of three conditions: recovery housing alone (RH), abstinence-contingent recovery housing with reinforcement-based treatment RBT (RH + RBT) or usual care (UC). RH and RH + RBT participants received 12 weeks of paid recovery housing contingent upon drug abstinence. RH + RBT participants also received 26 weeks of RBT, initiated concurrently with recovery housing. Assessments were conducted at 1, 3 and 6 months after treatment enrollment.
Setting Out-patient drug-free substance abuse treatment program in Baltimore, Maryland.
Participants Patients (n = 243) who completed medication-assisted opioid detoxification.
Measurements Primary outcome was drug abstinence (opioid- and cocaine-negative urine and no self-reported opioid or cocaine use in the previous 30 days). Secondary outcomes included abstinence at all time-points (1, 3 and 6 months), days in recovery housing and employment.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Maryland
-
Baltimore, Maryland, États-Unis, 21224
- Behavioral Pharmacology Research Unit
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- completes residential detoxification for use of opiates and/or cocaine
- willing to go to outpatient aftercare
- agrees to random assignment; signs informed consent
Exclusion Criteria:
- moving out of town
- primary substance use does not include opiates or cocaine
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Recovery housing plus counseling
Intensive counseling in a 5-day per week program plus abstinence-contingent rent payment in a community recovery house.
Intervention lasts 12 weeks with follow-up at 12 and 24 weeks post treatment entry.
|
Participants receive 3 months of abstinence-contingent program-supported rent payment in community recovery housing.
They also receive intensive outpatient counseling (both individual and group) focused on relapse prevention skills training, goal setting, employment seeking and recreational activities.
|
|
Expérimental: Recovery Housing only
Abstinence-contingent payment for recovery housing rent in absence of any formal counseling.
Intervention lasts 12 weeks with follow-up at 12 and 24 weeks post treatment entry.
|
Participant may receive up to 3 months of abstinence-contingent rent payment in community recovery housing but is not invited to participate in intensive counseling.
|
|
Comparateur actif: Usual Care Referral
Participants receive referral resources for community substance abuse counseling and recovery housing but no formal treatment or help with rent payments.
All participate in follow-up data collection.
|
Participants are referred to an outpatient program of their choosing with an appointment made for them.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
abstinence from opiates and cocaine
Délai: 6 months post randomization
|
Free in the community plus self report of no drug use in past 30 days verified with negative urine screen.
|
6 months post randomization
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Maxine Stitzer, Ph.D., Johns Hopkins University
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- DA13003
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .